Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer
August 05, 2020 07:30 ET
|
BDA International
New York City, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Saliva-Based Test Powered by Co-Diagnostics (NASDAQ:CODX) a Game Changer Maxim reiterate Buy with a price target of $30 Earlier this week,...
H.C. Wainwright reiterates ‘Buy’ for Co-Diagnostics (NASDAQ:CODX) with a $35 Price Target as COVID-19 Surge Boosts Testing Demand
July 14, 2020 07:30 ET
|
BDA International
New York City, July 14, 2020 (GLOBE NEWSWIRE) -- Analyst Yi Chen of H.C. Wainwright & Co. reiterated his ‘buy’ coverage on Co-Diagnostics (NASDAQ:CODX), the Utah-based molecular diagnostics...
Co-Diagnostics (NASDAQ:CODX) to join Russell 2000® and 3000® Indexes
June 11, 2020 11:57 ET
|
BDA International
New York City, New York, June 11, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics (NASDAQ:CODX), announced earlier this week that the molecular diagnostics company is set to join the broad-market Russell...
Co-Diagnostics (NASDAQ:CODX) Analysts Set Price Target Between $30 and $36
May 28, 2020 09:00 ET
|
BDA International
New York City, May 28, 2020 (GLOBE NEWSWIRE) -- Analysts from H.C. Wainwright, Maxim Group and Litchfield Hills have all upgraded or reiterated Co-Diagnostics (NASDAQ: CODX) as “Buy” rating in the...
Co-Diagnostics (NASDAQ:CODX) Part of Silicon Slopes Initiative Inking “Big Dollar Contracts” for Coronavirus Testing
April 28, 2020 12:25 ET
|
BDA International
New York City, April 28, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a Utah biotech with a unique, patented molecular diagnostic testing platform, recently announced...
Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges
April 17, 2020 08:30 ET
|
BDA International
New York City, April 17, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges Co-Diagnostics (NASDAQ:CODX), with its unique, patented...
Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-19 Testing
March 25, 2020 11:30 ET
|
BDA International
NEW YORK CITY, March 25, 2020 (GLOBE NEWSWIRE) -- The global shortage of COVID-19 testing kits is hitting the United States and other nations hard, but a recent FDA policy change means that...
Buy for Co-Diagnostics (NASDAQ:CODX) Reiterated by H.C. Wainwright with $20 Price Target
March 11, 2020 09:30 ET
|
BDA International
New York City, March 11, 2020 (GLOBE NEWSWIRE) -- Analyst Yi Chen released additional coverage on Co-Diagnostics (NASDAQ:CODX), a Utah-based molecular diagnostics company, raising the firm’s price...
H.C. Wainwright Reiterates Buy on Co-Diagnostics (NASDAQ:CODX) with a $20 PT as Shipments to U.S and Overseas Markets Continue
March 10, 2020 15:11 ET
|
BDA International
NEW YORK CITY, March 10, 2020 (GLOBE NEWSWIRE) -- H.C. Wainwright analyst Yi Chen released additional coverage on Co-Diagnostics (NASDAQ:CODX), a Utah-based molecular diagnostics company, raising...
Co-Diagnostics (NASDAQ:CODX) Ready to Meet U.S Vice President’s Plea for More Domestic Tests
March 06, 2020 13:01 ET
|
BDA International
New York City, March 06, 2020 (GLOBE NEWSWIRE) -- Following US Health and Human Services Secretary Alex Azar declaring a US public health emergency on the potential threat that the novel coronavirus...